Protein metabolism in inflammatory bowel disease
- PMID: 3539713
- PMCID: PMC1434623
- DOI: 10.1136/gut.27.suppl_1.67
Protein metabolism in inflammatory bowel disease
Abstract
Major loss of body protein mass in inflammatory bowel disease is much less common than weight loss, which is often attributable to losses of other body, particularly water and fat. It does occur, however, in a few patients, especially in those with compromised food intake. It is due principally to the combined effects of diminished intake and excessive intestinal losses of amino nitrogen. Nitrogen metabolism is influenced not only by protein nutritional state and net nitrogen intake but also by disease activity. There is some evidence for abnormally low secretion of growth hormone in adolescents with inflammatory bowel disease and growth failure. Low serum albumin concentrations are not necessarily related to protein undernutrition and are the combined result of relatively reduced albumin synthesis, increased intestinal losses, and maldistribution between intravascular and extravascular spaces. Concentrations in the plasma of IgG and acute phase reactants may be raised despite increased losses into the bowel lumen. The prevention of total body protein depletion is achieved principally by maintaining adequate and often not supranormal intakes of a balanced source of amino nitrogen in a balanced diet given orally, enterally, or parenterally, combined with a medical or surgical approach to reduce disease activity: supranormal energy intakes are not beneficial.
Similar articles
-
The effect of disease, drug, and diet on whole body protein metabolism in adolescents with Crohn disease and growth failure.J Pediatr. 1982 Sep;101(3):345-51. doi: 10.1016/s0022-3476(82)80056-5. J Pediatr. 1982. PMID: 6809923
-
Rates of whole body protein synthesis and breakdown increase with the severity of inflammatory bowel disease.Gut. 1984 May;25(5):460-4. doi: 10.1136/gut.25.5.460. Gut. 1984. PMID: 6714789 Free PMC article.
-
Growth retardation in chronic inflammatory bowel disease.Gastroenterology. 1986 Oct;91(4):1019-21. doi: 10.1016/0016-5085(86)90709-2. Gastroenterology. 1986. PMID: 3743955 No abstract available.
-
Assessing nutritional state in inflammatory bowel disease.Gut. 1986 Nov;27 Suppl 1(Suppl 1):61-6. doi: 10.1136/gut.27.suppl_1.61. Gut. 1986. PMID: 3539712 Free PMC article. Review.
-
Nutritional management of inflammatory bowel disease.Gastroenterol Clin North Am. 1989 Mar;18(1):129-55. Gastroenterol Clin North Am. 1989. PMID: 2493426 Review.
Cited by
-
Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs.Clin Pharmacokinet. 2022 Oct;61(10):1365-1392. doi: 10.1007/s40262-022-01169-4. Epub 2022 Sep 3. Clin Pharmacokinet. 2022. PMID: 36056298 Free PMC article.
-
Anti-inflammatory Streptococcus thermophilus CNRZ160 limits sarcopenia induced by low-grade inflammation in older adult rats.Front Nutr. 2022 Sep 29;9:986542. doi: 10.3389/fnut.2022.986542. eCollection 2022. Front Nutr. 2022. PMID: 36245508 Free PMC article.
-
Protein synthesis rates in colon and liver: stimulation by gastrointestinal pathologies.Gut. 1992 Jul;33(7):976-81. doi: 10.1136/gut.33.7.976. Gut. 1992. PMID: 1644342 Free PMC article.
-
Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy.Therap Adv Gastroenterol. 2022 Mar 2;15:17562848221077837. doi: 10.1177/17562848221077837. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35251307 Free PMC article.
-
Evaluation of nutritional status using bioelectrical impedance analysis in patients with inflammatory bowel disease.Intest Res. 2022 Jul;20(3):321-328. doi: 10.5217/ir.2021.00022. Epub 2021 Jul 20. Intest Res. 2022. PMID: 34275256 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical